Limb spasticity
Limb spasticity is a major therapeutic indication in botulinum toxin practice, especially in rehabilitation medicine and neurology. It is useful in the encyclopedia because it connects toxin biology with functional treatment goals rather than only symptom labels.
Why botulinum toxin is relevant
Section titled “Why botulinum toxin is relevant”Botulinum toxin is relevant to limb spasticity because focal chemodenervation can reduce overactive muscle contraction in selected upper- or lower-limb patterns. This makes the topic an important bridge between core mechanism and practical treatment strategy.
Connected products and toxin types
Section titled “Connected products and toxin types”Limb spasticity is commonly associated with:
Why this node matters in the graph
Section titled “Why this node matters in the graph”This indication expands the site beyond migraine, autonomic symptoms, and focal dystonia into a broader rehabilitation context. It also strengthens links between therapeutic use, manufacturer portfolios, and the later clinical-practice layer. The injection anatomy overview page helps show why limb-pattern anatomy has to be interpreted differently from facial or cervical targets. The dose calculation overview page adds the total-session and site-distribution logic that often drives limb-pattern planning. The safety and adverse-effect framing page helps interpret functional weakness against rehabilitation goals rather than as a generic adverse signal. The Botox vs Dysport page provides a compact example of how two overlapping type A brands can still require careful reading in this setting.